US Regulatory Affairs Market Size, Share and Trend Analysis Report 2024-2030 by Service, Category, Indication, Product Stage, Service Provider, Company Size, End Use

Company logoCompany logo

Company logo

US Regulatory Affairs Market

US Regulatory Affairs MarketUS Regulatory Affairs Market

US Regulatory Affairs Market

Dublin, July 11, 2024 (GLOBE NEWSWIRE) — The report “US Market Size, Share and Trend Analysis by Service, Category, Indication, Product Stage, Service Provider, Company Size, End Application, Country and Segment Forecasts 2024-2030” has been added to Research & offering.

The US regulatory affairs market is expected to reach $7.71 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.0%

The regulatory landscape is constantly evolving and becoming more complex, with new laws and guidelines being introduced regularly. This complexity is driving demand for regulatory professionals who can navigate these complex requirements.

As a firm expands globally, compliance becomes increasingly difficult due to varying regulations in different countries. Regulatory affairs professionals help organizations navigate international regulatory frameworks and ensure market access. For example, according to a January 2024 update from Reuters, a number of U.S. law firms are expected to enter into merger agreements in 2024. Stockton & Kilpatrick Townsend recently announced a merger with smaller firms. Additionally, Fennemore Craig, a mid-sized firm founded in Phoenix, announced an expansion to Seattle this year.

Regulatory authorities are prioritizing patient safety and product quality, leading to stringent regulations that companies must adhere to. Regulatory professionals play a key role in ensuring products meet these standards while speeding up the approval process. As the healthcare industry evolves and competition increases, companies must stay ahead of the curve by effectively complying with regulations. Regulatory expertise is becoming a competitive advantage in getting products to market faster while meeting regulatory requirements.

US Regulatory Affairs Market Report Highlights

  • The services segment was dominated by regulatory work and publications, the share of which in 2023 amounted to over 16%, which resulted from the increasing outsourcing of these services by medium and large companies involved in the production of medical devices and biopharmaceuticals

  • The legal representation services segment is expected to grow the fastest in the forecast period

  • The medical devices segment held the largest market share in 2023. This is due to the increasing number of outsourcing activities in the field of medical devices by pharmaceutical companies, which allows them to focus on their core competencies

  • Oncology held the largest share in the market revenue in 2023. This can be attributed to the increasing incidence of cancer cases, which fosters the demand for effective and safe treatments

  • The immunology segment is expected to grow at the fastest rate at a CAGR of 10.4% during the forecast period owing to its ability to facilitate treatment of multiple neurological, cardiovascular, inflammatory and oncological diseases

  • Clinical trials accounted for the largest share of market revenues in 2023 due to the rising incidence of new diseases and the increased incidence of chronic diseases.

  • Third-party service providers accounted for the largest share of market revenue in 2023 and are expected to grow at the fastest CAGR during the forecast period

  • Mid-sized companies accounted for the largest share of market revenue in 2023 due to the existence of several mid-sized established suppliers, especially private ones, which is expected to contribute to the growth of the segment

  • The pharmaceutical companies segment dominated the market in 2023 and is expected to grow the fastest in the forecast period, driven by an increase in the number of authorized pharmaceutical products

Key Features:

Report Attribute


number of pages


Forecast period


Estimated Market Value (USD) 2023

$4.23 billion

Projected Market Value (USD) to 2030

$7.71 billion

Compound Annual Growth Rate


Regions covered

United States

The report discusses:

  • Market intelligence for effective decision-making

  • Market estimates and forecasts for 2018-2030

  • Development opportunities and trend analysis

  • Segment and regional revenue forecasts for market assessment purposes

  • Competitive Strategy and Market Share Analysis

  • A list of product innovations that will keep you ahead of the competition

  • The impact of COVID-19 and how to stay relevant in these rapidly changing markets

Featured companies

  • Accell Clinical Research, LLC

  • Genpakt


  • ICON plc

  • Promedica International

  • WuXi AppTec

  • Medpace

  • Charles River Laboratories

  • Labcorp Drug Development

  • Parexel International Corporation (MA)

  • Freyr

  • Pharmalex GmbH Company

  • NDA AB Group

  • Vigilance

  • BlueReg

  • Cambridge Regulatory Services

  • VCL

For more information on this report, please visit

About is the world’s leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, leading companies, new products and the latest trends.


CONTACT: CONTACT: Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900